Alector (ALEC) Revenue (2018 - 2026)
Alector (ALEC) reported Revenue of $1.0 million for Q1 2026, down 71.53% year-over-year from $3.7 million in Q1 2025, and down 83.23% on a QoQ basis from $6.2 million in Q4 2025.
Alector (ALEC) has 9 years of Revenue data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Revenue fell 71.53% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.4 million (down 79.15% YoY) and the FY2025 annual result came in at $21.0 million, down 79.07% from the prior year.
- Revenue retreated to $1.0 million in Q1 2026 per ALEC's latest filing, from $6.2 million in the prior quarter.
- Across five years, Revenue topped out at $79.9 million in Q2 2022 and bottomed at $1.0 million in Q1 2026.
- The 5-year median for Revenue is $15.1 million (2024), against an average of $20.8 million.
- Peak annual rise in Revenue reached 1115.76% in 2022, while the deepest fall reached 91.86% in 2022.
- Tracing ALEC's Revenue over 5 years: stood at $14.4 million in 2022, then rose by 5.19% to $15.2 million in 2023, then jumped by 257.08% to $54.2 million in 2024, then sank by 88.5% to $6.2 million in 2025, then plunged by 83.23% to $1.0 million in 2026.
- Per Business Quant, the three latest ALEC Revenue figures stand at $1.0 million (Q1 2026), $6.2 million (Q4 2025), and $3.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Alector | 238.87 Mn | 32.36 Mn | - | 1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | 6.24 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 7.87 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Dec 31, 2024 | 54.24 Mn |
| Sep 30, 2024 | 15.34 Mn |
| Jun 30, 2024 | 15.08 Mn |
| Mar 31, 2024 | 15.89 Mn |
| Dec 31, 2023 | 15.19 Mn |
| Sep 30, 2023 | 9.11 Mn |
| Jun 30, 2023 | 56.21 Mn |
| Mar 31, 2023 | 16.55 Mn |
| Dec 31, 2022 | 14.44 Mn |
| Sep 30, 2022 | 14.85 Mn |
| Jun 30, 2022 | 79.85 Mn |
| Mar 31, 2022 | 24.47 Mn |
| Dec 31, 2021 | 13.99 Mn |
| Sep 30, 2021 | 182.41 Mn |
| Jun 30, 2021 | 6.57 Mn |
| Mar 31, 2021 | 4.11 Mn |
| Dec 31, 2020 | 4.85 Mn |
| Sep 30, 2020 | 5.90 Mn |
| Jun 30, 2020 | 3.17 Mn |
| Mar 31, 2020 | 7.17 Mn |
| Dec 31, 2019 | 6.00 Mn |
| Sep 30, 2019 | 2.70 Mn |
| Jun 30, 2019 | 6.92 Mn |
| Mar 31, 2019 | 5.61 Mn |
| Dec 31, 2018 | 9.15 Mn |
| Sep 30, 2018 | 6.50 Mn |
| Jun 30, 2018 | 7.11 Mn |
| Mar 31, 2018 | 4.92 Mn |